Medtronic is recalling more than 700 OmniaSecure defibrillation leads, urging customers to quarantine and return them. The FDA has ruled this is a Class II recall. No adverse events have been reported.

Heartflow filed the lawsuit after Elucid received FDA clearance for its new AI-enabled FFR-CT software. Elucid, meanwhile, is standing behind its technology and plans on responding through the appropriate legal channels.

Andrew Einstein, MD, PhD, spoke to Cardiovascular Business about the potential benefits and limitations of using coronary CT angiography as a screening modality.

The procedure, believed to be the first of its kind, was performed at the 2026 European Association for Cardio-Thoracic Surgery annual meeting in Barcelona, Spain.

These findings left researchers asking questions about the risk assessment tools clinicians currently use on a daily basis.

Surgical bailout during TAVR is growing increasingly rare as time goes on. Does that mean it is time to rethink certain coverage policies? A new study and two separate editorials examined this topic in great detail.

SCAI surveyed its members to find out what they thought about potential changes to current TAVR policies. The responses to that survey helped influence the group's official stance. 

Eko Health's Core 300 stethoscope offers noise cancellation, amplification and a real-time display of the patient's heart data. Clinicians can also use the same device for traditional analog listening.

MRI scans have traditionally been used for extracellular volume assessments. That is starting to change, however, as cardiac CT moves beyond its typical focus on the coronary arteries.

The Acticor Sky CRT-DX, which secured FDA approval in April, has officially made its debut in the United States.

Ohio-based Riverain Technologies is now making its FDA-cleared suite of AI tools available through RapidAI’s Rapid Enterprise Platform.

"Particularly strong" performance among women in their 70s signals the importance of continuing screening into later ages, experts write in RSNA's Radiology: Imaging Cancer. 

Centene echoes complaints previously brought up by Alignment Health, accusing the Centers for Medicare & Medicaid Services of violating the Administrative Procedure Act. In both cases, a July judicial victory by another healthcare payer may set the precedent.